How much hypofractionated IMRT is too much for localized prostate cancer?

A report to be presented at the upcoming meeting of the American Society for Radiation Oncology (ASTRO) offers 5-year outcome data from a trial comparing conventional intensity-modulated radiation therapy (IMRT) to the more recently developed hypofractionated IMRT for men with localized prostate cancer. … READ MORE …

IMRT alone vs. HDR brachytherapy + IMRT — short-term outcomes are similar

There have been strong suggestions over the years (at least from some physician groups) that the combination of brachytherapy with external beam radiotherapy (EBRT) was associated with superior outcomes compared to the use of EBRT alone in treatment of localized prostate cancer. … READ MORE …